Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

Everolimus Phase II data to show efficacy and safety in patients with Waldenstrom's macroglobulinemia (WM) who had relapsed or become resistant to prior treatment (Abstract #587; Monday, December 7, 2009 at 3:45 PM CST)(1)
  • Panobinostat data from two early phase studies to show efficacy in heavily pre-treated patients with multiple myeloma and Hodgkin lymphoma (Abstract #3852; Monday, December 7, 2009 at 6:00 PM CST; Abstract #923; Tuesday, December 8, 2009 at 8:30 AM CST)(2)(7)
  • Midostaurin early stage data will demonstrate benefit in patients with FLT3-mutated acute myeloid leukemia when used in combination with chemotherapy (Abstract #634; Monday, December 7, 2009 at 5:15 PM CST)(3)
  • INCB18424 data from a Phase II study in advanced polycythemia vera (PV) and essential thrombocythemia (ET) refractory to hydroxyurea (Abstract #311; Monday, December 7, 2009, 8:00 AM CST)(5)( )
  • INCB18424 long-term follow-up data to demonstrate durable clinical, functional and symptomatic responses with excellent hematological safety in patients with myelofibrosis (Abstract #756; Monday, December 7, 2009 at 5:45 PM CST)(4)
  • Exjade two-year data from EPIC (Evaluation of Patients Iron Chelation with Exjade) trial to show benefit of Exjade for chronically transfused beta-thalassemia patients by continuing to significantly reduce toxic iron that can damage the heart (Abstract #4062; Monday, December 7, 2009 at 6:00 PM CST)(6)
  • BHQ880 preliminary Phase I study data in combination with Zometa(®) (zoledronic acid) and an approved anti-myeloma therapy in patients with relapsed or refractory multiple myeloma who experienced a prior skeletal-related event (Abstract #750; Monday, December 7, 2009 at 5:45 PM CST)(8)(9)
  • The Novartis Oncology pipeline features compounds in all phases of development, including six in late-stage development, and encompasses a broad array of therapeutic strat
    '/>"/>

    SOURCE Novartis
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

    Related medicine technology :

    1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
    2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
    3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
    4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
    5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
    6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
    7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
    8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
    9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
    10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
    11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... , July 3, 2015 ... del 100% de participación en ZAO "Biocom" en ... marca la incursión de Lupin en el mercado ... RUB en ventas, colocándolo como uno de los ... (IMS Health). Durante más de una década, el ...
    (Date:7/2/2015)... HOUSTON, TX and VANCOUVER , ... the "Company") (TSX-V: EPI) announced today that its common shares ... Capital Market ("NASDAQ") under the symbol "EPIX". ESSA ... Company will retain its listing on the TSX Venture Exchange ... the listing of the common shares on the NASDAQ, each ...
    (Date:7/2/2015)... Fla. , July 2, 2015  Fort ... is pleased to announce that its Consumer Group ... Beverages") to Kerry Group plc (ISE: KRZ) ("Kerry"), ... taste and nutrition systems, as well as functional ... and pharmaceutical markets. Farlie Turner served as the ...
    Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
    ... a privately held company that has developed an all new ... it has reached an agreement with The Tech Group ... , to be the premier manufacturer of the Trio™ ... contract also includes development and engineering services from Insight Product ...
    ... Jan. 6, 2012 Breckenridge Pharmaceutical, Inc.announced that it ... different Abbreviated New Drug Applications (ANDA) during the 2011 ... (5) each year for the next several years.  These ... IV opportunities -- both blockbuster and niche products -- ...
    Cached Medicine Technology:Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 2Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™" 3
    (Date:7/3/2015)... Lenexa, KS (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... Okla. One of the top-ranked executive search firms in the healthcare industry, B. ...
    (Date:7/3/2015)... Orange, CT (PRWEB) , ... July 03, 2015 , ... ... at home is a good blender and easily accessible, quality ingredients. Aurora Natural is ... your smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , ...
    (Date:7/3/2015)... ... , ... Jennifer Renee Hanes, DO is the new Medical Director of its ... independent freestanding emergency rooms in the United States. , “We are excited to welcome ... Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , ...
    (Date:7/3/2015)... ... ... Selfie on a Stick ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... smartphone has an incredibly powerful camera built into it. And when someone is traveling ...
    (Date:7/3/2015)... ... ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... community with free fitness training and indoor fitness boot camp classes for 24 straight ... thousands of charity dollars and ended with a $10,000 donation to the Jumpstart organization. ...
    Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
    ... 28 MSA (NYSE: MSA ) today announced that net ... $293.2 million for the second quarter of 2008, a decrease of $66.0 ... 2009 was $12.5 million, or 35 cents per basic share, a decrease ... cents per basic share, for the same quarter last year. , ...
    ... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
    ... experts say , TUESDAY, July 28 (HealthDay News) -- Antiviral ... elderly and should be reserved for young people, suggest researchers ... on the spread of the H1N1 virus. , If the ... drugs would not significantly reduce death rates among people older ...
    ... , DES PLAINES, Ill., July 28 Our ... for thousands of nurses, emergency departments are the sources of injury. ... that more than half of emergency nurses report experiencing physical violence ... shoved," "scratched," and "kicked." One in four has experienced such ...
    ... , , ... 28 CVS Caremark (NYSE: CVS ) announced today ... President/Chief Operating Officer of MinuteClinic, the company,s retail-based health clinic subsidiary, ... In his new roles, Dr. Sussman will be responsible for ...
    ... 28 On a routine day, Specialty Silicone Fabricators in ... drains, catheter systems, intravenous drug delivery devices and pacemaker leads. ... of these miniature products. Considering that silicone is a highly ... is no small achievement. , , ...
    Cached Medicine News:Health News:MSA Announces Second Quarter Results 2Health News:MSA Announces Second Quarter Results 3Health News:MSA Announces Second Quarter Results 4Health News:MSA Announces Second Quarter Results 5Health News:MSA Announces Second Quarter Results 6Health News:MSA Announces Second Quarter Results 7Health News:MSA Announces Second Quarter Results 8Health News:Save Swine Flu Drugs for Younger Patients, Study Urges 2Health News:More Than Half of Emergency Department Nurses Have Been Physically Assaulted at Work, New Study Finds 2Health News:More Than Half of Emergency Department Nurses Have Been Physically Assaulted at Work, New Study Finds 3Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 2Health News:CVS Caremark Names Andrew J. Sussman, M.D., as President/Chief Operating Officer of MinuteClinic 3Health News:When You Make Things That Get Implanted in People, Small Things Count 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: